Scholars Central

PerspectivePublished 2016

Efficacy of Dendritic Cell-Based Cancer Immunotherapy

Authors: Shigetaka Shimodaira, Yumiko Higuchi, Ryu Yanagisawa, Masato Okamoto, Shigeo Koido

Biochemistry & Analytical Biochemistry

Volume 5 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dendritic cells (DCs) have antigen-specific bioactivity against tumor-associated antigens. The acquisition of tumor immunity with DC vaccination could be determined using both tetramer analysis and interferon γ-producing clones in enzyme-linked immunosorbent spot assays. A combination of DC vaccination with low-dose metronomic therapy and chemoradiotherapy would contribute to an enhanced acquired immunity for cancer therapy. The efficacy of DC vaccination may provide a survival benefit in some patients with cancer by achieving a prolonged quality-adjusted life year.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biochemistry & Analytical Biochemistry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Analytical Biochemistry
  • SubjectBiochemistry & Biotechnology
  • SubjectChemistry
  • BylineArticles whose byline prints “Shigetaka Shimodaira”
  • BylineArticles whose byline prints “Yumiko Higuchi”
  • BylineArticles whose byline prints “Ryu Yanagisawa”
  • BylineArticles whose byline prints “Masato Okamoto”
  • BylineArticles whose byline prints “Shigeo Koido”